Editor-in-Chief: Prof. Steven T. Rosen, City of Hope National Med Center, USA.
Deputy Editor-in-Chief: Prof. Elizabeth Lihua Budde, City of Hope National Med Center, USA.

International Journal of Lymphoma Therapeutics (IJLT) is a gold open-access, peer-reviewed publication providing a global perspective and experience with modern therapies targeting Hodgkin’s Disease, Non-Hodgkin’s Lymphomas, and Chronic Lymphocytic Leukemia. The journal provides an international forum for the dissemination of high-quality scientific insights and impactful advances to academics, clinicians, pharmacists, allied healthcare professionals, and the public worldwide. IJLT seeks to publish comprehensive thematic reviews by leading experts in the field that highlight current and emerging treatment strategies, including CAR T cell therapy, antibody-drug conjugates, T cell engagers, checkpoint inhibitors, therapies targeting signaling pathways, and approaches involving transcriptional and epigenetic regulation. This journal is published quarterly online by Scilight Press. More